TREA

98609776

Follow

Information

  • Trademark
  • 98609776
  • Serial Number
    98609776
  • Filing Date
    June 20, 2024
    9 months ago
  • Transaction Date
    April 02, 2025
    2 days ago
  • Status Date
    April 01, 2025
    3 days ago
  • Published for Opposition Date
    February 04, 2025
    a month ago
  • Location Date
    April 01, 2025
    3 days ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    HETZEL, DANNEAN
  • Attorney Docket Number
    034175.125
    Attorney Name
    Scott D. Woldow
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a stylized globe.
  • GS0051: Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations for the treatment of autoimmune diseases, illnesses and conditions; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 6/20/2024 - 9 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/12/2025 - 2 months ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 1/12/2025 - 2 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/13/2025 - 2 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/15/2025 - 2 months ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/29/2025 - 2 months ago
    6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/4/2025 - a month ago
    7 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/4/2025 - a month ago
    8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/1/2025 - 3 days ago
    9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM